Genesis Healthcare introduces new sequencing center in Asia, breaking price industry benchmark to accelerate genomic research and drug discovery

SINGAPORE, Oct 31, 2018 — Genesis Healthcare Co., Japan’s pioneer genetic testing and research company, today announced the launch of its new Sequencing Center in Ebisu, Tokyo, Japan.


The introduction of the New Sequencing Centerenables the company to conduct high-quality whole genome sequencing (WGS) — the analysis of the entire genomic DNA sequencing — for 99,800 JPY (889 USD) per specimen.


The New Sequencing Centeris equipped with the high-throughput Next Generation Sequencer (NGS), which is capable of analyzing a large number of specimens at one time, allowing to break the benchmarking price of 1,000 USD in Japan for the first time and extended to South East Asia.


With its low-price WGS service, Genesis Healthcare is expecting to support research institutes, medical institutes, and pharmaceutical companies to identify causes of rare diseases as well as accelerate the process for new drug discovery.


Available immediately, researchers can engage with Genesis Healthcare through its headquarters in Japan as well as regional offices in Singapore and Taiwan.


Genesis Healthcare is a leader in genetic research and testing with more than 650,000 users undertaking DNA testing across Asia.



Genesis Healthcare Co.
Corporate site:
Press inquiries: Yoshito Funabashi

Business inquiries: Ryo Itaya